Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin

Yi Li(Shanghai University of Traditional Chinese Medicine), Feng Wang(Nantong Tumor Hospital)
Journal of Experimental & Clinical Cancer Research
September 7, 2022
10.1186/s13046-022-02482-3
Cited by 29

Related Papers

AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma
|Science|2007|648
Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway
|Oncotarget|2015|346
Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studies
|European Journal of Cancer|2015|283
The bone microenvironment invigorates metastatic seeds for further dissemination
|Cell|2021|240
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia
|Alzheimer s Research & Therapy|2021|200